Compare TBBK & LKFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TBBK | LKFT |
|---|---|---|
| Founded | 1999 | 1999 |
| Country | United States | Belgium |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 2005 | 2007 |
| Metric | TBBK | LKFT |
|---|---|---|
| Price | $46.91 | $32.17 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 6 |
| Target Price | ★ $76.00 | $30.41 |
| AVG Volume (30 Days) | ★ 414.4K | 255.8K |
| Earning Date | 10-29-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.69 | N/A |
| EPS | ★ 2.86 | N/A |
| Revenue | ★ $141,147,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.56 | N/A |
| P/E Ratio | $17.69 | ★ N/A |
| Revenue Growth | ★ 20.85 | N/A |
| 52 Week Low | $47.01 | $25.68 |
| 52 Week High | $73.02 | $32.60 |
| Indicator | TBBK | LKFT |
|---|---|---|
| Relative Strength Index (RSI) | 33.14 | 67.58 |
| Support Level | N/A | $28.50 |
| Resistance Level | $51.47 | $32.41 |
| Average True Range (ATR) | 1.47 | 0.67 |
| MACD | 0.26 | 0.18 |
| Stochastic Oscillator | 9.70 | 84.98 |
The Bancorp Inc is a financial holding company. The Company's operations are classified under three segments: fintech, Credit Solutions (three sub-segments), and corporate. The fintech segment includes the deposit balances and non-interest income generated by prepaid, debit, and other card-accessed accounts, ACH processing, and other payments-related processing. It also includes loan balances and interest and non-interest income from credit products generated through payment relationships; Credit Solutions includes REBL (real estate bridge lending), comprised of apartment building rehabilitation loans, and Others; Corporate includes the Company's investment securities, corporate overhead, and expenses which have not been allocated to segments.
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.